Comments
Loading...

BridgeBio Pharma Inc (BBIO) Stock Price, Quote, News & History

BBIONASDAQ
$79.17
5.847.96%
Last update: Feb 12, 11:27 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-584.82M
Investing Cash Flow (TTM)
-13.37M
Financing Cash Flow (TTM)
835.41M
Free Cash Flow (TTM)
-597.61M
Capital Expenditure (TTM)
-12.80M
Net Change in Cash (TTM)
237.22M

Analyst Trends and Forecast

9
Oct 25
3
Nov 25
2
Dec 25
4
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$14.25B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
39.48
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-5.74%
Earnings Yield % (FWD)
-2.76%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$10.09

Company Debt

Total Debt
$1.85B
LT Debt
$1.85B
LT Debt Issuance (TTM)
$1.08B
LT Debt Repayment (TTM)
-$459.00M
Total Cash
$642.95M
Debt to Equity
-
Issuance of Debt (TTM)
$616.00M
Repayment of Debt (TTM)
-$459.00M

Key Statistics

Open
$84.85
Close
-
Volume / Avg.
4.84M / 2.45M
Day Range
$78.95 - $84.94
52 Wk Range
28.33 - 81.33
Market Cap
$15.17B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
56
Short Interest
17.47%
Days to Cover
7.14

About

Sector
Health Care
Industry
Biotechnology
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disor...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BBIO
ONC

FAQ

Q

How do I buy BridgeBio Pharma (BBIO) stock?

A

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BridgeBio Pharma (BBIO) competitors?

Q

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

A

BridgeBio Pharma has a consensus price target of $72.44.

Q

What is the current price for BridgeBio Pharma (BBIO)?

A

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $79.165 last updated February 12, 2026 at 11:27 AM EST.

Q

Does BridgeBio Pharma (BBIO) pay a dividend?

A

There are no upcoming dividends for BridgeBio Pharma.

Q

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

A

BridgeBio Pharma does not have any upcoming earnings scheduled.

Q

Is BridgeBio Pharma (BBIO) going to split?

A

There is no upcoming split for BridgeBio Pharma.

Q

What sector and industry does BridgeBio Pharma (BBIO) operate in?

A

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.